NIH-funded research Career grant

Advancing Kidney Care in Medicare Advantage: How MA Enrollment Affects Dialysis Patients

Official title: A quasi-experimental evaluation of Medicare Advantage enrollment on dialysis care and outcomes

Funded at Stanford University · NIH-11353001 · Data updated 2026-11-12

This project looks at how switching to Medicare Advantage affects the treatment and everyday care of people with end-stage kidney disease who need dialysis.

More Dialysis research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$169,991
NIH project number1K08DK147769-01
Project IDNIH-11353001 on NIH RePORTER

Who could benefit from this research

Could help

Adults with end-stage kidney disease who are on dialysis and are enrolled in or eligible for Medicare Advantage.

Less likely to help

Patients who remain in fee-for-service Medicare without any switch to MA or those with minimal interaction with MA plans may see no difference.

What this research studies

If you or a loved one relies on dialysis, this study examines whether enrolling in Medicare Advantage changes how medications are used, costs, and access to care. Researchers will compare real-world data from Medicare claims to see how MA enrollment influences drug use, out-of-pocket expenses, emergency visits, hospitalizations, and dialysis treatment adherence. The study uses real-world evidence and quasi-experimental methods to try to separate the effect of MA from other factors. It also investigates which patient characteristics and regional factors are linked to choosing MA. The goal is to better understand whether MA plans improve or worsen care quality and access for dialysis patients.

Why it matters

Potential benefit: If MA enrollment improves access and reduces unnecessary costs, patients on dialysis could experience smoother care and fewer interruptions in treatment.

How similar studies have gone: Evidence from related areas suggests mixed results; this study addresses a specific high-risk population (dialysis patients) and MA impact.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Caldwell, Jillian Scott — Stanford University
  • Study coordinator: Caldwell, Jillian Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.